2,405 material Form 8-K filings that 2,035 companies we cover made with the SEC in November 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 1,081 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Lake Superior Acquisition Corp. signed an Amended and Restated Business Combination Agreement on November 3, 2026, with Openmarkets Group and related parties, restructuring the pre-closing ownership of Pubco and the order of the transactions. The closing exchange consideration of $300 million is unchanged, as are the milestone consideration terms, and the outside date is extended to March 31, 2027, which gives shareholders a longer window for the deal to close.
Closing exchange consideration of $300,000,000, payable in Pubco ordinary shares at a deemed value of $10.00 per share
Milestone consideration of up to $300,000,000 (license) and up to $400,000,000 (performance), held in escrow as Pubco shares totaling $700,000,000
Outside date extended from December 31, 2026 to March 31, 2027
Lake Superior is to be liquidated after closing, with its assets transferred to Pubco
Bio-Techne's board declared a $0.08 per share cash dividend for the quarter ended September 30, 2026. The payment is conditional on the pending transaction with Merck KGaA, Darmstadt, Germany not closing on or before the November 13, 2026 record date, so the dividend tie-in to that deal matters to shareholders.
Dividend of $0.08 per share for the quarter ended September 30, 2026
Payable November 23, 2026 to common shareholders of record at close of business November 13, 2026
Dividend applies only if the Merck KGaA transaction has not closed on or before November 13, 2026
Future dividends will be considered by the Board on a quarterly basis
Par Pacific reported third quarter 2026 net income attributable to stockholders of $353.3 million, or $7.11 per diluted share, up from $262.6 million, or $5.16 per share, a year earlier. The results include a $187.2 million small refinery exemption benefit from the EPA, and the company agreed to sell its 46% interest in Laramie Energy, with about $120 million in cash proceeds expected by year end.
Revenues were $3,052.4 million in Q3 2026, compared with $2,012.9 million in Q3 2025.
Adjusted net income attributable to stockholders was $531.5 million, or $10.70 per diluted share, including a $187.2 million SRE impact.
The EPA granted full and partial small refinery exemptions in August 2026, which the company recorded as a gain in the third quarter.
The Laramie Energy sale is expected to close in Q4 2026, with about $120 million in cash proceeds expected by year end.
Avista Corp. reported third-quarter 2026 GAAP net income of $49 million, or $0.57 per diluted share, up from $29 million, or $0.36, a year earlier. Non-GAAP utility earnings rose to $33 million, or $0.38 per share, from $30 million, or $0.37, and the company confirmed its 2026 non-GAAP utility earnings guidance of $2.52 to $2.72 per diluted share.
Q3 2026 GAAP EPS $0.57 vs. $0.36; non-GAAP utility EPS $0.38 vs. $0.37
Year-to-date GAAP EPS $2.11 vs. $1.51; non-GAAP utility EPS $1.76 vs. $1.67
2026 non-GAAP utility EPS guidance confirmed at $2.52 to $2.72; CEO expects the midpoint
Company expects to issue up to $15 million of common stock in 2026 and up to $220 million of long-term debt in 2027
Hecla reported third quarter 2026 sales of $395 million, up 18% from the prior quarter, and income from continuing operations of $150 million, or $0.22 per share, versus $118 million, or $0.18 per share, in the second quarter. The company raised the low end of its 2026 silver production guidance, improved its cost guidance, and lowered its capital investment guidance, while also suppressing Keno Hill milling rates from the fourth quarter to preserve permitted tailings capacity. The filing also added Dale Andres to the Board and declared a $0.00375 per share dividend.
Sales of $394.8 million from continuing operations, up from $333.9 million in the prior quarter, driven mainly by timing of sales at Greens Creek
Record free cash flow from continuing operations of $151 million; cash and cash equivalents of $692 million at September 30, 2026
2026 silver production guidance of 15.3-16.1 million ounces, with the low end raised from 15.1 million; total capital investment guidance lowered to $198-$214 million
Dividend of $0.00375 per share payable on or about December 8, 2026, to holders of record on November 23, 2026
3M agreed on November 3, 2026 to a settlement intended to resolve most PFAS-related personal injury claims in the AFFF multidistrict litigation. The company will contribute a nominal $7.35 billion from 2026 through 2034, with a present value of $5.8 billion, and will record that amount as a pre-tax charge in the fourth quarter of 2026. The company says the charge does not change its previously issued 2026 guidance, and payments depend on claimant participation thresholds.
Nominal commitment of $7.35 billion over 2026 to 2034; present value of $5.8 billion
Pre-tax charge of $5.8 billion in Q4 2026, treated as a special item in adjusted results; 3M says 2026 guidance is unchanged
$50 million payment due in 2026 and no payments in 2027; payments subject to claimant participation thresholds
Settlement covers about 99% of current personal injury claims, involving roughly 115,000 to 120,000 eligible plaintiffs; 3M does not admit liability
Ashland reported preliminary fourth-quarter fiscal 2026 sales of $498 million, up 4% from the prior-year quarter, and adjusted EBITDA of $121 million, up 2%. GAAP results were weaker: a net loss of $16 million compared with net income of $32 million a year earlier. The company also issued fiscal 2027 guidance of $1,905 million to $1,975 million in sales and $405 million to $435 million in adjusted EBITDA.
Q4 sales were $498 million, up 4%; sales volumes rose 3% and pricing rose 2%.
Net loss was $16 million, or ($0.35) per diluted share; adjusted diluted EPS was $1.12 versus $1.08 a year earlier.
Specialty Additives adjusted EBITDA fell 31% to $20 million, while Life Sciences adjusted EBITDA rose 16% to $64 million.
Fiscal 2027 guidance: sales of $1,905 million to $1,975 million and adjusted EBITDA of $405 million to $435 million; fiscal 2026 adjusted EBITDA was $385 million.
On October 28, 2026, Stewards, Inc. sold an unsecured convertible promissory note with a principal amount of $6,050,000 to Crom Structured Opportunities Fund I, LP for $5,500,000. The note matures in 12 months, and the investor can convert it into common stock from January 31, 2027, at 90% of the lowest daily VWAP over the prior five trading days, which could add substantial dilution for shareholders. The company plans to use about $4,937,000 in net proceeds to fund its proposed acquisition of PIXL, LLC, though no definitive agreement has been signed.
Note: $6,050,000 principal, $5,500,000 purchase price, 10% original issue discount, due in 12 months
Conversion from January 31, 2027 at 90% of the lowest five-day VWAP, with a full-ratchet anti-dilution adjustment
Share reserve of at least 7,000,000 shares; issuance above 45,309,740 shares (19.99%) requires stockholder approval, given by majority holders by written consent on October 28, 2026
Placement agent E.F. Hutton & Co. received a $440,000 cash fee and warrants for 121,109 shares at $2.498
Z Squared Inc. elected Jeffery Harris, its Chief Technology Officer, as a director effective November 3, 2026, filling the seat left vacant by Michelle Burke's May 22, 2026 resignation. Harris is an employee and executive officer, so he is not independent, but three of the five directors remain independent, keeping a majority under Nasdaq rules. He receives no additional director compensation.
Jeffery Harris, age 40, elected director effective November 3, 2026, filling the vacancy left by Michelle Burke's resignation
Board remains at five directors; three (Adam Sohn, Bryan Fuerst, Kenneth Cooper) are independent
Harris is not named to any board committee and receives no additional director compensation
Filing notes ongoing commercial relationships with Paradox Infrastructure LLC and Paradox Energy LLC, in which Harris holds membership interests
Avidia Bancorp filed an investor presentation for a November 5, 2026 conference that reports third-quarter 2026 results. Net income rose to $8.6 million, or $0.47 per share, from $7.2 million, or $0.39 per share, in the second quarter, and the company completed its $30 million stock repurchase plan on November 3, 2026.
Third-quarter 2026 net income was $8.6 million, up from $7.2 million in the second quarter of 2026.
Diluted EPS was $0.47 versus $0.39 in the prior quarter; total revenue rose to $31.2 million from $29.9 million.
The $30 million stock repurchase plan was completed on November 3, 2026, with 1.36 million shares repurchased (6.8%).
Net interest margin was 3.86%, up from 3.64% in the second quarter.
Global Water Resources reported third-quarter 2026 revenue of $16.3 million, up 5.0% year over year, while net income fell $0.7 million to $1.0 million, or $0.03 per diluted share. Management attributed the profit decline mainly to higher depreciation and net interest expense from recent rate base investments, and nine-month revenue rose 12.2%.
Q3 2026 total revenue rose 5.0% to $16.3 million; net income was $1.0 million, or $0.03 per diluted share, versus $1.7 million, or $0.06, in Q3 2025.
Nine-month revenue rose 12.2% to $47.4 million; nine-month net income was $3.4 million, or $0.12 per diluted share, versus $3.9 million, or $0.15.
Depreciation, amortization and accretion rose 30.4% in the quarter to $4.6 million, from $3.6 million.
The ACC is scheduled to deliberate the GW-Santa Cruz and GW-Palo Verde settlement at its November 4, 2026 open meeting; if approved, new GW-Santa Cruz rates take effect December 1, 2026.
Flotek reported third quarter 2026 revenue of $114.4 million, up 104% from a year earlier, and raised its full-year 2026 guidance for revenue and Adjusted EBITDA. Net income fell 35% to $13.3 million because the year-earlier quarter included a $12.6 million non-cash tax benefit. The company also outlined a 2027 Data Analytics capital plan of $15 million to $20 million, partly funded by a term loan closed in September.
Q3 2026 revenue $114.4 million, up 104% from $56.0 million; the company cites its highest quarterly revenue in twelve years
Net income $13.3 million, or $0.34 per diluted share, versus $20.4 million, or $0.53, in Q3 2025
Adjusted EBITDA $19.5 million, up 87% from $10.4 million a year earlier
2026 guidance raised: revenue $382-$390 million (previously $360-$370 million); Adjusted EBITDA $59-$62 million (previously $50-$54 million)
Picard Medical's board appointed Richard Fang, Ph.D., as permanent, full-time Chief Executive Officer effective October 28, 2026; he had served as interim CEO since June 18, 2026 and remains Chairman. The filing also discloses related-person loans from a Fang-affiliated entity, and the company had not received the $1.0 million of external funding that would have kept the earliest of those loans from coming due, so they are now payable on terms yet to be determined.
Richard Fang, Ph.D., appointed permanent CEO effective October 28, 2026; salary remains $0.4 million with no new compensation arrangement
Fang-affiliated fund lent $0.5 million at 0% interest under five loans from July 29 to October 16, 2026; no principal repaid as of October 29, 2026
As of October 29, 2026, no external funding of at least $1.0 million received; earliest loans now due on payment terms to be determined
Separate $0.7 million loan from Fang Family Fund I, LLC at 6% interest, due February 28, 2027
EagleRock Land reported third-quarter 2026 revenue of $43.3 million and net income of $11.3 million, up from $17.5 million of revenue and a $4.9 million net loss in the third quarter of 2025. The company raised its full-year 2026 Adjusted EBITDA guidance to a range of $133 million to $137 million from a prior midpoint of $131 million, and also disclosed a new 35,000-acre dedication with Double Eagle V and two Midland Basin acquisitions.
Q3 2026 total revenue was $43.3 million, versus $17.5 million in Q3 2025 and $46.8 million in Q2 2026 on a normalized basis.
Q3 2026 Adjusted EBITDA was $34.0 million, with an Adjusted EBITDA Margin of 78.5%; Free Cash Flow was $31.8 million.
Full-year 2026 Adjusted EBITDA guidance was raised to $133 million to $137 million, with about $2 million of the $4 million midpoint increase attributed to Intrepid Ranch.
Subsidiary DE IV Flow signed a water system management agreement with DEF Operating, an affiliate of a more than 5% shareholder; total debt at September 30, 2026 was $70 million.
Wabtec priced a $500 million offering of 5.900% Senior Notes due 2037 on November 2, 2026. The company plans to use the proceeds, together with borrowings under its revolving credit facilities, short-term facilities and/or commercial paper, to repay its 3.450% Senior Notes due November 15, 2026. The sale is expected to close on November 4, 2026.
Offering: $500 million aggregate principal of 5.900% Senior Notes due February 25, 2037, priced November 2, 2026
Use of proceeds: repay the 3.450% Senior Notes due 2026 at maturity on November 15, 2026, alongside other borrowings
Expected closing: November 4, 2026, subject to customary closing conditions
Joint book-running managers: BofA Securities, Citigroup Global Markets, PNC Capital Markets and TD Securities
CHS Inc. declared regular quarterly dividends on five series of its preferred stock on November 3, 2026. The payments are $0.50, $0.492188, $0.443750, $0.421875 and $0.468750 per share, each on a $25.00 per share preferred, payable December 31, 2026 to holders of record on December 16, 2026. The filing is a routine dividend notice and does not change results or the company's outlook.
Five preferred series declared: 8% Cumulative Redeemable, Class B Series 1, Series 2 and Series 3 (Reset Rate), and Series 4
Per-share dividends of $0.50, $0.492188, $0.443750, $0.421875 and $0.468750 on $25.00 per share preferred
Payable December 31, 2026 to shareholders of record on December 16, 2026
Avantor's compensation committee approved a special long-term incentive award for Executive Vice President and Chief Legal and Compliance Officer Claudius Sokenu, recognizing his work in litigation, regulatory management, dispute resolution and corporate governance. The award is 62,305 restricted stock units granted October 31, 2026, under the company's 2019 Equity Incentive Plan. The filing describes a routine compensation grant that does not change executive leadership and gives no financial results.
Award: 62,305 restricted stock units granted October 31, 2026, to Claudius Sokenu
Vesting: equal installments on the first three anniversaries of the grant date, subject to continued employment
Approved by the Compensation and Human Resources Committee on October 30, 2026
Enovix disclosed that Arthi Chakravarthy, its Chief Legal Officer and Corporate Secretary, has departed the company, effective October 30, 2026. The filing does not give a reason for the departure or name a successor.
Arthi Chakravarthy, Chief Legal Officer and Corporate Secretary, departed effective October 30, 2026
Filing dated November 3, 2026, signed by Ryan Benton, Interim Chief Executive Officer
No successor or replacement arrangement is named in the filing
SLR Investment Corp. reported net investment income of $17.8 million, or $0.33 per share, for the quarter ended September 30, 2026, down from $21.6 million, or $0.40 per share, a year earlier. Net asset value fell to $17.83 per share from $18.00 at June 30, 2026, and the board declared a $0.31 per share quarterly distribution, which the company said its net investment income covered.
Net investment income was $17.8 million, or $0.33 per share, versus $21.6 million, or $0.40 per share, a year earlier; flat sequentially per management.
Net increase in net assets from operations was $7.6 million, or $0.14 per share, versus $23.3 million, or $0.43 per share, a year earlier.
Net asset value was $17.83 per share at September 30, 2026, compared with $18.00 at June 30, 2026.
Quarterly distribution of $0.31 per share is payable December 28, 2026, to holders of record as of December 14, 2026.
Redwood Trust agreed to repurchase $53,125,000 of trust preferred securities from Hildene Capital Management for $45,156,250 plus a $500,000 fee, and the investor agreed to waive the company's REIT maintenance covenant. The Board also approved a plan to revoke the company's REIT election in the first quarter of 2027, adopted a tax benefits preservation plan, and declared a rights dividend, which matter to shareholders because they change the company's tax status, ownership-transfer restrictions, and stock-ownership protections.
Repurchase of $53,125,000 liquidation amount of trust preferred securities at 85% of liquidation amount, or $45,156,250, plus accumulated unpaid distributions, paid in three installments with the last due by February 15, 2027 or the REIT re
Plan to revoke REIT election in the first quarter of 2027 and transition to a C-corporation beginning with the 2027 taxable year
Tax benefits preservation plan declares one right per common share to holders of record on November 16, 2026, exercisable at $20.00 per right
Press release estimates an initial book value benefit of $0.73 to $0.77 per share in the fourth quarter of 2026, and a one-for-five reverse stock split effective January 4, 2027
Concentrix Corporation announced that Chinnu Susan Varghese will succeed Andre Valentine as Chief Financial Officer effective December 1, 2026. Mr. Valentine will remain in the role in the near term and stay through the second quarter of fiscal 2027 to support the transition.
Chinnu Susan Varghese joins Concentrix on November 9, 2026 and becomes CFO on December 1, 2026.
Andre Valentine stays on as CFO in the near term and is expected to remain with the company through the second quarter of fiscal 2027.
Ms. Varghese previously was Senior Vice President and Group Controller at Marelli and CFO, Global Growth Markets at Cognizant.
Matador Resources reported third quarter 2026 results on November 3, 2026, with oil and natural gas revenue of $1.22 billion, up 51% from a year earlier, while GAAP net income of $172.1 million was slightly below the $176.4 million reported in the third quarter of 2025. The company raised its full-year 2026 production guidance and said it repaid $150 million of debt in October 2026 and increased its annual dividend, which matters to shareholders because the revenue growth and dividend increase come alongside a slight dip in GAAP earnings per share.
Oil and natural gas revenue was $1.22 billion in Q3 2026, up from $810 million in Q3 2025.
GAAP net income was $172.1 million, or $1.39 per diluted share, versus $176.4 million, or $1.42 per diluted share, a year earlier; adjusted EPS was $2.08 versus $1.36.
Full-year 2026 production guidance was raised to 223,000 to 224,000 BOE per day, from 218,500 to 223,500 BOE per day in August 2026.
Annual dividend increased to $1.75 per share from $1.50, a 17% increase, and $150 million of borrowings were repaid in October 2026.
Seaboard reported third-quarter 2026 net sales of $2,771 million, up from $2,540 million a year earlier, but net earnings attributable to Seaboard fell to $28 million from $109 million as operating income dropped to $13 million from $84 million. For the nine months, net earnings rose to $300 million from $243 million, and the board declared a quarterly cash dividend of $2.25 per share.
Three months ended October 3, 2026: net sales $2,771 million vs. $2,540 million; earnings per share $29.23 vs. $113.71
Nine months ended October 3, 2026: net sales $8,093 million vs. $7,336 million; earnings per share $313.22 vs. $251.47
Quarterly cash dividend of $2.25 per share, payable November 23, 2026, to holders of record on November 13, 2026
Titan Acquisition Corp. furnished an investor presentation under Regulation FD for its proposed business combination with OpenPayd Holdings Limited, for use in meetings with existing and potential shareholders. The presentation reports first-half revenue of $47.5 million, up 43% year over year, but the filing does not report new audited results or final deal terms, and the company states that the transaction may not be consummated as described.
Exhibit 99.1 is an investor presentation dated November 2026, furnished under Item 7.01 and tied to the business combination described in an 8-K filed June 1, 2026, as amended July 9, 2026.
The presentation cites H1 revenue of $47.5 million, up 43% year over year, and more than 1,260 clients.
Figures as of October 31, 2026 include $360 billion+ annualized transaction volume and $107 million of Annual Recurring Revenue, which the company says is not an IFRS measure.
The presentation says a Nasdaq listing is anticipated by calendar Q4 2026, and that terms are under negotiation and subject to change.
Talos Energy reported a third-quarter 2026 net loss of $81.2 million, or $0.49 per diluted share, on total revenues of $596.0 million. Adjusted net income was $99.3 million, or $0.58 per share, and the company raised its full-year 2026 production guidance while lowering its capital expenditure range. The mixed result matters to shareholders because the GAAP loss contrasts with higher adjusted profit and higher output.
Total revenues of $596.0 million; GAAP net loss of $81.2 million ($0.49 per diluted share); adjusted net income of $99.3 million ($0.58 per share)
Third-quarter production of 91.5 MBoe/d exceeded guidance; full-year 2026 production guidance raised to 92.5 to 94.5 MBoe/d from 85.0 to 90.0 MBoe/d
Capital expenditure guidance lowered to $475 million to $525 million from $500 million to $550 million; cash operating expenses guidance raised to $580 million to $600 million from $560 million to $590 million
Acquisition of deepwater assets from Shell completed September 22, 2026, with a final net cash purchase price of $420 million; 1.4 million shares repurchased for $23.6 million in the quarter
Ovintiv Inc. reported third quarter 2026 net earnings of $549 million and Non-GAAP Free Cash Flow of $680 million, alongside an agreement to acquire Logan Energy Corp. for approximately $890 million. The company returned $467 million to shareholders through buybacks and dividends while maintaining its full-year guidance.
Third quarter net earnings were $549 million, with Non-GAAP Free Cash Flow of $680 million.
Announced an agreement to acquire Logan Energy Corp. for a total transaction value of approximately $890 million.
Board of Directors declared a quarterly dividend of $0.30 per share, payable on December 31, 2026.
Third quarter production averaged 631 thousand barrels of oil equivalent per day.
Primoris reported third-quarter 2026 revenue of $2.0 billion, down 10.4% from a year earlier, and net income of $51.3 million, or $0.95 per diluted share, versus $1.73 in the third quarter of 2025. The decline was mainly due to lower renewables activity in the Energy segment, and the company updated its full-year 2026 guidance while also declaring a dividend and authorizing a $250 million share purchase program.
Q3 2026 revenue was $2.0 billion, down 10.4%; Energy segment revenue fell 17.6%.
Diluted EPS was $0.95 versus $1.73; adjusted diluted EPS was $1.20 versus $1.88.
Full-year 2026 diluted EPS guidance is $1.20 to $1.35; adjusted EPS guidance is $2.10 to $2.25.
Board declared a $0.08 per share dividend payable about January 15, 2027, and authorized a $250 million buyback with no expiration date.
Avidia Bancorp, Inc. completed its previously reported plan to repurchase up to $30 million in value of its common stock on November 3, 2026. The company bought 1,355,565 shares at a weighted average price of $22.10 per share, excluding commissions and excise taxes, which reduces the number of shares outstanding for existing shareholders.
Buyback plan of up to $30 million in value completed on November 3, 2026
1,355,565 shares repurchased at a weighted average price of $22.10 per share
Price excludes commissions and excise taxes; filing made under Item 8.01 (Other Events)
Weis Markets reported third quarter 2026 total revenue of $1.28 billion, up 3.0%, with net income of $22.21 million and earnings per share of $0.90, compared with $0.69 a year earlier. Higher fuel sales, new stores and a higher gross profit margin drove the improvement, while pharmacy pricing changes under the Inflation Reduction Act weighed on sales. The company also declared a $0.34 quarterly dividend.
Q3 2026 total revenue rose 3.0% to $1.28 billion; comparable store sales rose 1.3%, but fell 1.2% excluding fuel.
Gross profit margin rose to 25.5% from 24.8%; income from operations rose 38.6% to $28.51 million.
Year-to-date net income was $72.92 million, or $2.95 per share, versus $61.73 million, or $2.38 per share, a year earlier.
Board declared a $0.34 per share quarterly dividend, payable November 23, 2026, to holders of record as of November 9, 2026.
AH Realty Trust's operating partnership entered new credit agreements on October 28, 2026, providing a $150.0 million revolving credit facility and three term loans totaling $500.0 million, which replace four prior loan facilities. The filing also describes a separate $121.8 million secured term loan for subsidiaries that own the Constellation Tower property, with the financing terms and covenants taking effect for shareholders as a refinancing of existing debt.
On October 28, 2026, the operating partnership signed a Fourth Amended and Restated Credit Agreement with Bank of America, N.A. as administrative agent, including a $150.0 million revolver maturing October 28, 2031, a $200.0 million 4-year
A separate $100.0 million 7-year term loan maturing October 28, 2033 was arranged with Toronto Dominion (Texas) LLC, with an accordion feature allowing increases up to $250.0 million maximum outstanding.
The new loans replace a $355.0 million revolver, a $350.0 million term loan, a $135.0 million term loan with Manufacturers and Traders Trust Company, and a $95.0 million term loan with Toronto Dominion (Texas) LLC.
Constellation subsidiaries entered a $121.8 million term loan maturing October 28, 2029 with PNC Bank, N.A., priced at Daily Simple SOFR plus 1.80% and secured by the Constellation Tower property.
At its October 29, 2026 annual meeting, Autonomix Medical stockholders approved an increase of 750,000 shares under the 2023 Stock Plan and authorized the board to seek a reverse stock split of between 1-for-2 and 1-for-25. All six director nominees were elected, and Forvis Mazars, LLP was ratified as the independent auditor for the year ending March 31, 2027. The votes give the board flexibility on share count and equity awards, but the filing does not say whether a reverse split will be pursued.
Annual meeting held October 29, 2026; 905,610 shares voted, about 46% of 1,959,938 shares outstanding as of the September 8, 2026 record date.
2023 Stock Plan amended to add 750,000 shares; total issuable under the plan is 750,353 shares.
Reverse split proposal approved with 775,257 votes for and 110,036 against, authority valid until the one-year anniversary of the meeting.
Plan amendment approved with 225,651 votes for and 39,672 against.
NeOnc Technologies Holdings announced that data from its intranasal NEO100 and oral NEO212 programs will be presented in two posters on November 13, 2026, at the 31st Annual Meeting of the Society for Neuro-Oncology in Philadelphia. The filing is an announcement of scheduled presentations and contains no financial results, guidance, or new financing terms.
Two poster presentations scheduled for Friday, November 13, 2026, 7:30 to 9:30 p.m. EST, at the Pennsylvania Convention Center in Philadelphia
NEO100 poster: updated Phase 1/2a results in recurrent WHO Grade III/IV IDH1-Mutant Astrocytoma, presented by Thomas C. Chen, MD, PhD
NEO212 poster: Phase 1 safety, pharmacokinetics and early activity signals in TMZ-Resistant recurrent GBM, presented by Josh Neman, PhD
Both NEO100 and NEO212 remain investigational and have not been approved by any regulatory authority
On October 28, 2026, Optimum Communications increased its board from nine to eleven directors and appointed Elizabeth Abrams and Daniel Silvers, both determined to be independent. The board also created a special committee of these two directors with authority to evaluate potential financing, restructuring, or recapitalization transactions and conflict-of-interest matters involving related parties.
Board size increased from nine to eleven directors effective October 28, 2026.
Each new director will receive a monthly fee of $75,000 under an Independent Director Agreement.
Silvers' brother is a partner at Ropes & Gray LLP, which the company paid approximately $11 million for legal services since January 1, 2025.
Special Committee members are Abrams and Silvers, with delegated power to review potential strategic and financial transactions.
XMax Inc. released unaudited preliminary third-quarter 2026 results showing net sales of about $6.42 million, down from $9.76 million a year earlier, and an expected net loss of $12.10 million to $13.10 million, driven mainly by a non-cash unrealized loss. The numbers are not final: closing procedures are incomplete, the auditor has not reviewed them, and the complete results are due in a Form 10-Q by November 16, 2026.
Q3 2026 net sales of about $6.42 million versus $9.76 million in Q3 2025; gross margin of about 13.9% versus 10.1%
Expected Q3 2026 net loss of $12.10 million to $13.10 million, primarily a non-cash unrealized loss
Nine-month net sales of about $10.94 million versus $14.95 million; expected nine-month net income of $19.50 million to $20.50 million, mainly a non-cash unrealized gain
Board approved a share repurchase program of up to $30 million; final Form 10-Q expected on or before November 16, 2026
Acadia Realty Trust filed a new automatic shelf registration on Form S-3 to replace its 2023 shelf, which expires November 7, 2026, and amended its at-the-market equity offering program. The amendment adds Citizens JMP Securities as an additional sales agent and forward purchaser, and about $199 million remains available under the program. The filing describes routine capital-raising housekeeping, and it signals that the company can issue new common shares under the program, which would dilute existing holders if used.
New automatic shelf registration on Form S-3 filed November 3, 2026, replacing the 2023 shelf that expires November 7, 2026
Amendment No. 1 covers common shares with an aggregate sale price of up to $500 million under the at-the-market program
As of the amendment date, up to $199,062,233.91 in common shares remained available for issuance under the program
Citizens JMP Securities, LLC added as an additional sales agent and forward purchaser
Summit Hotel Properties reported third-quarter 2026 results with a net loss attributable to common stockholders of $7.7 million, or $0.07 per diluted share, down from $11.3 million, or $0.11, a year earlier. Total revenues rose to $185.7 million from $177.1 million, and the company again raised its full-year 2026 guidance ranges for pro forma RevPAR growth, Adjusted EBITDAre, and Adjusted FFO, which may matter to shareholders because it reflects higher expected earnings for the year.
Q3 2026 net loss attributable to common stockholders was $7.7 million ($0.07 per diluted share), versus $11.3 million ($0.11) in Q3 2025.
Q3 2026 total revenues were $185.7 million, up from $177.1 million; Adjusted EBITDAre rose 11.8% to $43.9 million.
Full-year 2026 Adjusted FFO guidance was raised to $102.5 million–$107.5 million ($0.85–$0.89 per share); Adjusted EBITDAre guidance is $181 million–$186 million.
Quarterly common dividend of $0.08 per share was declared on October 27, 2026, payable November 30, 2026 to holders of record as of November 16, 2026.
GXO Logistics furnished an investor presentation reporting third-quarter 2026 results, with revenue of $3.6 billion, up 5.7% from a year earlier, and organic revenue growth of 6.4%. Adjusted diluted EPS rose 13% to $0.89, while adjusted EBITDA was flat at $251 million, and full-year 2026 guidance was unchanged.
Q3 2026 revenue was $3.6 billion versus $3.4 billion in Q3 2025; organic revenue growth was 6.4%.
Adjusted diluted EPS was $0.89 versus $0.79; adjusted EBITDA was $251 million in both periods.
Free cash flow fell to $85 million from $187 million in Q3 2025; net leverage was 2.7x, unchanged year over year.
FY 2026 guidance was reaffirmed: adjusted EBITDA of $945 million to $965 million and adjusted diluted EPS of $2.95 to $3.15.
Global Industrial reported third-quarter 2026 net sales of $389.5 million, up 10.2% from a year earlier, and diluted EPS from continuing operations of $0.64, up from $0.48. Management said tariff refunds added about $0.04 to EPS in the quarter. The board also declared a $0.28 regular dividend and a $1.00 special dividend per share, payable to shareholders of record on November 16, 2026.
Q3 net sales were $389.5 million versus $353.6 million; average daily sales rose 8.5%.
Diluted EPS from continuing operations was $0.64 versus $0.48; tariff refunds benefited EPS by about $0.04.
Dividends: $0.28 regular and $1.00 special per share, record date November 16, 2026, payable November 23, 2026.
Nine-month net sales were $1,126.5 million and diluted EPS from continuing operations was $2.00, versus $1.48; tariff refunds benefited nine-month EPS by about $0.46.
Solid Power reported third quarter 2026 total revenue and grant income of $1.2 million, down from $4.6 million a year earlier, while its net loss narrowed to $24.4 million, or $0.11 per share, from $25.9 million. Management lowered its 2026 cash investment guidance to $75 million to $85 million from $85 million to $100 million, and the company reported total liquidity of $397.6 million and no debt.
Q3 2026 total revenue and grant income was $1.2 million, versus $4.6 million in Q3 2025; operating expenses rose to $31.1 million from $29.0 million
Net loss was $24.4 million, or $0.11 per share, compared with a net loss of $25.9 million, or $0.14 per share, in Q3 2025
2026 cash investment guidance was reduced to $75 million to $85 million from $85 million to $100 million
Total liquidity was $397.6 million as of September 30, 2026, with no debt
On November 2, 2026, Rockwell Medical agreed to acquire Vantive's in-center hemodialysis business in 35 jurisdictions, with a $125 million base price financed mainly by seller loans and a convertible note from Vantive affiliates. The company also withdrew its previously issued 2026 guidance, citing expected transaction and financing expenses. Shareholders face substantially higher debt, potential dilution from the convertible note, and closing that is expected in mid-2027 and subject to regulatory approvals.
Equity and Asset Purchase Agreement with Vantive Limited dated November 2, 2026, covering the in-center hemodialysis business in 35 jurisdictions
Base purchase price of $125 million, funded by two $50 million term loans and a $25 million convertible note from Vantive affiliates, plus up to $45 million in earnout payments
2026 guidance for net sales, gross margin, adjusted EBITDA and operating cash flow withdrawn
Expected closing in mid-2027, subject to regulatory approvals; combined business projected annual revenue of $400 million to $450 million
InMed Pharmaceuticals reported a first-quarter fiscal 2027 net loss of $2.3 million for the quarter ended September 30, 2026, up from $1.7 million a year earlier, and cash fell to $1.0 million from $2.2 million at June 30, 2026. The company said its cash is expected to fund operations into mid-November, and it reported shareholders' equity of negative $1.2 million, below Nasdaq's $2.5 million minimum, with a compliance deadline of March 15, 2027. Shareholders vote on the proposed Mentari merger at a meeting on November 4, 2026.
Net loss of $2.3 million, or $0.42 per share, for the quarter ended September 30, 2026, compared with a net loss of $1.7 million, or $0.44 per share, a year earlier
Cash and cash equivalents of $1.0 million at September 30, 2026, versus $2.2 million at June 30, 2026; cash expected to fund operations into mid-November
Shareholders' equity was negative $1.2 million at September 30, 2026; Nasdaq set a March 15, 2027 deadline to regain compliance with its $2.5 million minimum
Annual general and special meeting on November 4, 2026, to consider proposals needed to complete the Mentari merger, which is expected to close in the fourth quarter of calendar 2026
On November 3, 2026, the Board of Directors of National Bank Holdings Corporation declared a cash dividend of $0.33 per share on its Class A common stock. The press release describes the payment as an increase to the quarterly dividend, but the filing does not state the prior amount. Future dividends remain subject to Board approval and will depend on the company's financial position, results and capital requirements.
Cash dividend of $0.33 per share on Class A common stock, declared November 3, 2026
Record date is November 27, 2026 (close of business); payment date is December 15, 2026
Press release, filed as Exhibit 99.1, calls it an increase to the quarterly dividend; prior dividend amount not stated
Future dividends are at the Board's discretion and depend on financial position, results, cash flows and capital requirements
GXO reported third-quarter 2026 revenue of $3.6 billion, up 5.7% year over year, and diluted EPS of $0.56 versus $0.51 a year earlier. The company reaffirmed its full-year 2026 guidance, but free cash flow fell to $85 million from $187 million, and adjusted EBITDA was flat at $251 million.
Revenue $3.6 billion, up 5.7% year over year; organic revenue growth 6.4%
Diluted EPS $0.56 vs. $0.51; adjusted diluted EPS $0.89 vs. $0.79
Free cash flow $85 million vs. $187 million; operating cash flow $156 million vs. $232 million
Full-year 2026 guidance reaffirmed; Investor Day set for November 16, 2026
Kadant reported third-quarter 2026 revenue of $313.2 million, up 15% from a year earlier and a company record, with GAAP EPS up 26% to $2.96 and adjusted EPS up 21% to a record $3.64. The company raised its 2026 adjusted EPS guidance to $12.58 to $12.73 from $12.43 to $12.68 and narrowed its revenue guidance to $1.195 to $1.210 billion, though gross margin slipped 50 basis points to 44.7%.
Q3 bookings rose 22% to $291 million; organic bookings rose 10%, excluding a 12% contribution from acquisitions
Q3 net income rose 27% to $35 million, and operating cash flow rose 33% to a record $63 million
Revised 2026 GAAP EPS guidance is $9.88 to $10.03, up from a low end of $9.78; Q4 2026 revenue is expected at $287 to $302 million
Organic revenue grew four percent in Q3; acquisitions contributed 11 percent
ProShares Trust II announced a 1-for-2 reverse split of the ProShares VIX Mid-Term Futures ETF (VIXM), effective before market open on November 19, 2026. The company says the split will not change the value of a shareholder's investment, but fractional shares created by the split will be redeemed for cash, which may be a taxable event.
VIXM ticker stays the same; the fund receives new CUSIP 74347Y649 and each two pre-split shares become one post-split share.
Fractional post-split shares will be redeemed for cash and sent to the shareholder's broker of record.
The same press release covers 15 ETFs in total: three forward splits (EET and ROM at 3:1, BIB at 2:1) and 12 reverse splits, including VIXM.
Capital City Bank Group furnished a third quarter 2026 investor presentation under Regulation FD, posting it to its website and filing it as Exhibit 99.1 to a Form 8-K dated November 3, 2026. The filing itself contains no financial results, guidance, or other figures, so its direct effect on shareholders is limited to the presentation's content, which the filing does not describe.
Investor presentation for third quarter 2026 posted to www.ccbg.com
Presentation furnished as Exhibit 99.1 and not deemed filed under Section 18 of the Exchange Act
Filing signed November 3, 2026 by Jeptha E. Larkin, Executive Vice President and Chief Financial Officer
On November 3, 2026, Procter & Gamble closed an underwritten public offering of four series of euro-denominated notes under its existing Form S-3 shelf registration, totaling €3.25 billion in principal. The notes mature between 2030 and 2046 and carry coupons from 3.750% to 4.625%, so the offering adds long-term debt to the company's balance sheet.
Four tranches: €750 million due November 3, 2030 at 3.750%; €1.0 billion due November 3, 2034 at 4.100%; €750 million due November 3, 2038 at 4.250%; €750 million due November 3, 2046 at 4.625%
Offering closed on November 3, 2026, under Registration No. 333-299472
Legal opinions filed as Exhibits 5(a) and 5(b); the filing does not state the use of proceeds
IFF's board approved one-time equity and cash incentive awards for executives, including the CEO and CFO, tied to closing the previously announced sale of its Food Ingredients business. The board also adopted amended bylaws that allow stockholder meetings to be held solely by remote communication.
Named executive awards total $700,000 for CEO J. Erik Fyrwald (RSUs with three-year cliff vesting), CFO Michael DeVeau, and President Leticia Gonçalves Lourenço, plus $350,000 for Yuvraj Arora
No award vests or is paid unless the Food Ingredients sale closes; awards are forfeited if the agreement is terminated
Amended and restated bylaws took effect October 28, 2026 and permit remote-only stockholder meetings
Accendra Health's Executive Vice President and Chief Operating Officer, Perry Bernocchi, will cease to be an executive officer under a transition agreement dated October 29, 2026, and serve as Strategic Advisor to the CEO until December 31, 2026, unless his employment ends earlier. He keeps his current base salary and remains eligible for his 2026 annual bonus at target and for applicable severance, which matters to shareholders as a senior operating leadership change.
Perry A. Bernocchi, EVP and Chief Operating Officer, ceases to be an executive officer under agreement dated October 29, 2026
Serves as Strategic Advisor to the Chief Executive Officer until December 31, 2026, unless employment ends earlier
Keeps current base salary and remains eligible for 2026 annual bonus at current target
Remains eligible for severance under Officer Severance Policy or change of control agreement, as applicable
Ring Energy disclosed that director Richard Harris is retiring from its board of directors, effective October 28, 2026. The filing states his decision was not the result of any dispute or disagreement with the company on its operations, policies, or practices.
Richard Harris notified the board on October 28, 2026 of his retirement.
Retirement is effective October 28, 2026.
Filing states no dispute or disagreement with the company led to the decision.
8-K signed by CFO Sundip S. Johl on November 3, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.